Skip to content

Clinical trials

Major Depressive Disorder trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Hungary Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20103
20113
20122
20142
20164
20173
20183
20202
20213
20223
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated7
Recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC7
Otsuka Pharmaceutical Development & Commercialization, Inc.5
H. Lundbeck A/S4
AstraZeneca3
Intra-Cellular Therapies, Inc.2
Naurex, Inc, an affiliate of Allergan plc2
Neurocrine Biosciences2
Seaport Therapeutics2
Shire2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder37
Depressive Disorder6
Mood Disorders5
Mental Disorders4
Anxiety Disorders3
Anhedonia2
Depressive Disorder, Treatment-Resistant2
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.